Boulton DW, DeVane CL, Liston HL, Markowitz JS.In vitroP-glycoprotein affinity for
atypical and conventional antipsychotics. Life Sci 2002;71:163–169.
Boyd R, Stern R, Stewart B, Wu X, Reyner E, Zegarac E, Randinitis E, Whitfield L.
Atorvastatin coadministration may increase digoxin concentrations by inhibition of
intestinal P-glycoprotein-mediated secretion. J Clin Pharmacol 2000;40:91–98.
Boyer JL, Meier PJ. Characterizing mechanisms of hepatic bile acid transport utilizing
isolated membrane vesicles. Methods Enzymol 1990;192:517–533.
Breedveld P, Pluim D, Cipriani G, Wielinga P, Van Tellingen O, Schinkel AH, Schellens
JHM. The effect of Bcrp1 (Abcg2) on thein vivopharmacokinetics and brain
penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer
resistance protein and P-glycoprotein inhibitors to enable the brain penetration of
imatinib in patients. Cancer Res 2005;65:2577–2582.
Brown GR. Cephalosporin-probenecid drug interactions. Clin Pharmacokinet 1993;
24:289–300.
Buechler M, Koenig J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. cDNA
cloning of the hepatocyte canalicular isoform of the multidrug resistance protein,
cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant
rats. J Biol Chem 1996;271:15091–15098.
Buss N, Snell P, Bock J, Hsu A, Jorga K. Saquinavir and ritonavir pharmacokinetics
following combined ritonavir and saquinavir (soft gelatin capsules) administration.
Br J Clin Pharmacol 2001;52:255–264.
Calvo MV, Martin-Suarez A, Martin Luengo C, Avila C, Cascon M, Dominguez-Gil
Hurle A. Interaction between digoxin and propafenone. Ther Drug Monit
1989;11:10–15.
Campbell SD, de Morais SM, Xu JJ. Inhibition of human organic anion transporting
polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia. Chem
Biol Interact 2004;150:179–187.
Center MS, Zhu Q, Sun H. Mutagenesis of the putative nucleotide-binding domains of
the multidrug resistance associated protein (MRP). Analysis of the effect of these
mutations on MRP mediated drug resistance and transport. Cytotechnology
1998;27:61–69.
Chang T, Benet LZ, Hebert MF. The effect of water-soluble vitamin E on cyclosporine
pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 1996;59:297–303.
Chang X-B, Hou Y-X, Riordan JR. Stimulation of ATPase activity of purified
multidrug resistance-associated protein by nucleoside diphosphates. J Biol Chem
1998;273:23844–23848.
Chen C, Liu X, Smith BJ. Utility of Mdr1-gene deficient mice in assessing the impact of
P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and
development. Curr Drug Metab 2003a;4:272–291.
Chen C, Scott D, Hanson E, Franco J, Berryman E, Volberg M, Liu X. Impact of
Mrp2 on the biliary excretion and intestinal absorption of furosemide,
probenecid, and methotrexate using eisai hyperbilirubinemic rats. Pharm Res
2003b;20:31–37.
Christensen H, Asberg A, Holmboe AB, Berg KJ. Coadministration of grapefruit juice
increases systemic exposure of diltiazem in healthy volunteers. Eur J Clin Pharmacol
2002;58:515–520.
REFERENCES 187